Compounds > clarithromycin
Page last updated: 2024-08-25

clarithromycin and oseltamivir

clarithromycin has been researched along with oseltamivir in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's6 (60.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jongwutiwes, U; Leelarasamee, A; Puthavathana, P; Siritantikorn, S; Tantipong, H1
Chida, J; Ito, C; Iwase, K; Kido, H; Mizuno, D; Sawabuchi, T; Suzuki, S; Talukder, SR; Togari, H; Watanabe, I1
Chida, J; Fujihashi, K; Fujii, K; Indalao, IL; Kataoka, K; Kido, H; Konoha, K; Mizuno, D; Takahashi, E1
Chan, JFW; Chan, KH; Chan, TC; Chen, H; Cheng, VCC; Cheung, MKS; Fok, M; Hung, IFN; Lau, JYN; Leung, W; Li, P; Liu, KSH; Tam, A; To, KKW; Wong, TL; Yuen, KY; Zhang, AJ; Zhang, R1
Ishii, H; Ishimoto, H; Kadota, JI; Mukae, H; Nishida, C; Noguchi, S; Sakamoto, N; Umeki, K; Yamasaki, K; Yatera, K1
Mazzetti, A; Neary, JD1
Hung, IFN; Yuen, KY1
Chi, H; Chiu, NC; Huang, CY; Huang, DT; Huang, FY; Huang, LM; Lee, CW; Tai, YL; Tu, YH; Wang, JY1

Reviews

1 review(s) available for clarithromycin and oseltamivir

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for clarithromycin and oseltamivir

ArticleYear
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
    Chest, 2017, Volume: 151, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Clarithromycin; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hospitalization; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Length of Stay; Male; Mortality; Naproxen; Nasopharynx; Oseltamivir; Severity of Illness Index; Treatment Outcome; Viral Load

2017

Other Studies

8 other study(ies) available for clarithromycin and oseltamivir

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Fulminating influenza pneumonia in the elderly: a case demonstration.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2008, Volume: 91, Issue:6

    Topics: Age Factors; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Clarithromycin; Humans; Influenza A virus; Influenza, Human; Male; Oseltamivir; Pneumonia, Viral

2008
Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza.
    Respirology (Carlton, Vic.), 2009, Volume: 14, Issue:8

    Topics: Adolescent; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Clarithromycin; Cough; Drug Therapy, Combination; Humans; Immunoglobulin A; Infant; Influenza A virus; Influenza, Human; Nasal Mucosa; Oseltamivir; Prevalence; Retrospective Studies; RNA, Viral; Treatment Outcome

2009
Oral clarithromycin enhances airway immunoglobulin A (IgA) immunity through induction of IgA class switching recombination and B-cell-activating factor of the tumor necrosis factor family molecule on mucosal dendritic cells in mice infected with influenza
    Journal of virology, 2012, Volume: 86, Issue:20

    Topics: Administration, Oral; Animals; Antibodies, Neutralizing; Antiviral Agents; B-Cell Activating Factor; Bronchi; Clarithromycin; Cytidine Deaminase; Dendritic Cells; Female; Immunity, Mucosal; Immunoglobulin A; Immunoglobulin Class Switching; Influenza A Virus, H1N1 Subtype; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Spleen; Tumor Necrosis Factor-alpha

2012
The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases.
    Respiratory investigation, 2017, Volume: 55, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Clarithromycin; Cohort Studies; Comorbidity; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Influenza A virus; Influenza, Human; Male; Middle Aged; Neuraminidase; Oseltamivir; Phosphorous Acids; Pneumonia; Prospective Studies; Treatment Outcome; Zanamivir

2017
Outcome Switching in Triple Therapy in Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
    Chest, 2018, Volume: 154, Issue:4

    Topics: Clarithromycin; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Naproxen; Oseltamivir

2018
Response.
    Chest, 2018, Volume: 154, Issue:4

    Topics: Clarithromycin; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Naproxen; Oseltamivir

2018
Efficacy of clarithromycin-naproxen-oseltamivir combination therapy versus oseltamivir alone in hospitalized pediatric influenza patients.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:5

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Hospitalization; Hospitals, Pediatric; Humans; Infant; Influenza, Human; Male; Naproxen; Oseltamivir; Prospective Studies; Single-Blind Method; Treatment Outcome; Viral Load

2021